Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure-Reference-Cited by-同舟云学术

Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure

Published:2014-12-01 Issue:6 Volume:277 Page:717-726
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Trøseid M.¹²³⁴⁵,Ueland T.²³⁴,Hov J. R.²³⁴⁶⁷,Svardal A.⁸,Gregersen I.²⁴,Dahl C. P.²⁹¹⁰,Aakhus S.⁹,Gude E.⁹,Bjørndal B.¹¹,Halvorsen B.²³⁴,Karlsen T. H.²³⁴⁶¹²,Aukrust P.²³⁴⁵,Gullestad L.⁴⁸¹⁰¹¹¹³,Berge R. K.⁸¹¹,Yndestad A.²³⁴¹⁰

Affiliation:

1. Department of Infectious Diseases; Oslo University Hospital, Ullevål; Norway

2. Research Institute of Internal Medicine; Oslo University Hospital, Rikshospitalet; Norway

3. K.G. Jebsen Centre for Inflammation Research; Norway

4. Institute of Clinical Medicine; University of Oslo; Norway

5. Section of Clinical Immunology and Infectious Diseases; Oslo University Hospital Rikshospitalet; Norway

6. Department of Transplantation Medicine; Section of Gastroenterology; Oslo University Hospital; Norway

7. Norwegian PSC Research Center; Norway

8. Department of Clinical Science; University of Bergen; Norway

9. Department of Cardiology; Oslo University Hospital, Rikshospitalet; Norway

10. Centre for Heart Failure Research; Oslo University Hospital; Norway

11. Department of Heart Disease; Haukeland University Hospital; Bergen Norway

12. Norwegian PSC Research Center; Norway. Division of Gastroenterology; Institute of Medicine; University of Bergen; Bergen Norway

13. K.G. Jebsen Cardiac Research Center; University of Oslo; Oslo Norway

Funder

K.G. Jebsen Centre for Inflammation Research

Western Norway Regional Health Authority

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joim.12328/fullpdf

Reference26 articles.

1. Anti-inflammatory trials in chronic heart failure;Aukrust;Heart Fail Monit,2006

2. Gut microbiota and diabetes: from pathogenesis to therapeutic perspective;Burcelin;Acta Diabetol,2011

3. Altered intestinal function in patients with chronic heart failure;Sandek;J Am Coll Cardiol,2007

4. The gut and intestinal bacteria in chronic heart failure;Sandek;Curr Drug Metab,2009

5. Role of bacterial endotoxin in chronic heart failure: the gut of the matter;Charalambous;Shock,2007

Cited by 370 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trimethylamine-N-oxide and 5-year mortality: the role of gut microbiota-generated metabolite from the CORE-Thailand cohort;Scientific Reports;2024-09-11

2. Alterations in the sarcopenia index are associated with inflammation, gut, and oral microbiota among heart failure, left ventricular assist device, and heart transplant patients;The Journal of Heart and Lung Transplantation;2024-09

3. Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis;Molecular Medicine;2024-08-23

4. The gut microbiota derived metabolite trimethylamine N-oxide: Its important role in cancer and other diseases;Biomedicine & Pharmacotherapy;2024-08

5. Human Gut Microbiota in Cardiovascular Disease;Comprehensive Physiology;2024-06-27